Cholesterol metabolism in patients with chronic renal failure on hemodialysis

Journal of Nephrology

Volumn 16, Issue 6, 2003, Pages 850-854

  Igel Korcagova, Arina ^a   Raab, Peter ^b   Brensing, Karl August ^b   Pöge, Uwe ^a   Klehr, Hans Ulrich ^a   Igel, Michael ^a   von Bergmann, Klaus ^a   Sudhop, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Center of Hemodialysis   (Germany)

Author keywords

Bile acid synthesis; Campesterol; Cholesterol absorption; Cholesterol synthesis; Gas chromatography; HDL cholesterol; Mass spectrometry; Sitosterol

Indexed keywords

ALUMINUM OXIDE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BILE ACID; CALCITRIOL; CHOLESTEROL; FUROSEMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; RECOMBINANT ERYTHROPOIETIN; RESIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; BILE ACID SYNTHESIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTESTINE ABSORPTION; LIVER METABOLISM; PATHOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; BIOSYNTHESIS; BLOOD; FEMALE; MALE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; BILE ACIDS AND SALTS; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; INTESTINAL ABSORPTION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYTOSTEROLS; RENAL DIALYSIS; TRIGLYCERIDES;

EID: 1642527950     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bommer J, Strohbeck E, Goerich J, Bahner M, Zuna I. Arteriosclerosis in dialysis patients. Int J Artif Organs 1996; 19: 638-44.
2. Cheung AK, Wu LL, Kablitz C, Leypoldt JK. Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis 1993; 22: 271-6.
3. Assmann G, Cullen P, Fruchart C, Lewis B, Mancini M, Carmena R. Coronary heart disease prevention task force. Eur Heart J 1999; 20: 841-4.
4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
5. European Best Practice Guidelines for Haemodialysis. Nephrol Dial Transplant 2002; 17 (suppl 7): 88-109.
6. Wanner C, Quaschning T. Dyslipidemia and renal disease: pathogenesis and clinical consequences. Curr Opin Nephrol Hypertens 2001; 10: 195-201.
7. Lütjohann D, Meese CO, Crouse JR 3rd, von Bergmann K. Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in humans. J Lipid Res 1993; 34: 1039-46.
8. Czubayko F, Beumers B, Lammsfuss S, Lütjohann D, von Bergmann K. A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J Lipid Res 1991; 32: 1861-7.
9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
10. Hahn C, von Bergmann K. Relationship between the serum concentration of 7 alpha-hydroxycholesterol and fecal bile acid excretion in humans. Scand J Gastroenterol 1996; 31: 804-8.
11. Drukker A, Levy E, Bronza N, Stankiewicz H, Goldstein R. Impaired intestinal fat absorption in chronic renal failure. Nephron 1982; 30: 154-60.
12. Schurr D, Levy E, Goldstein R, Stankiewicz H, Pomeranz A, Drukker A. Intestinal fat malabsorption in the uremic rat. Int J Pediatr Nephrol 1987; 8: 129-34.
13. el-Lakany S, Eagon PK, Gavaler JS, Schade RR, Whiteside T, Van Thiel DH. Gastrointestinal function, morphology, and immune status in uremia. Nutrition 1940; 6: 461-8.
14. Wang SC, Lu KY, Chen SM, Young TK. Gastric emptying and intestinal transit of liquid and solid markers in rats with chronic uremia. Chin J Physiol 2001; 44: 81-7.
15. Don BR, Kaysen GA. Assessment of inflammation and nutrition in patients with end-stage renal disease. J Nephrol 2000; 13: 249-59.
16. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-57.
17. Björkhem I, Miettinen T, Reihner E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 1987; 28: 1137-43.
18. Kempen HJ, Glatz JF, Gevers Leuven JA, van der Voort HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988; 29: 1149-55.
19. Sutherland WH, Walker RJ, Ball MJ, Stapley SA, Corboy J, Robertson MC. Cholesterol precursor concentration in plasma from patients with chronic renal failure or kidney grafts. Clin Nephrol 1995; 43: 392-8.
20. Miettinen TA, Gylling H. Mortality and cholesterol metabolism in familial hypercholesterolemia. Long-term follow-up of 96 patients. Arteriosclerosis 1988; 8: 163-7.
21. Boberg KM, Einarsson K, Björkhem I. Apparent lack of conversion of sitosterol into C24-bile acids in humans. J Lipid Res 1990; 31: 1083-8.
22. Heinemann T, Axtmann G, von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 1993; 23: 827-31.